Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12599679 | Circular RNA compositions | 🖼🧊📄§ | 2026-04-14 | 2045-05-07 | 0 | 31 |
| 12599596 | Anti-tumor pharmaceutical composition based on immune checkpoint blockade and use thereof | 🖼🧊📄§ | 2026-04-14 | 2044-11-21 | 0 | 31 |
| 12599614 | Methods and pharmaceutical compositions for the treatment and prophylaxis of microbial infectious diseases and associated inflammatory disorders and for the treatment and prophylaxis of aging and associated diseases | 🖼🧊📄§ | 2026-04-14 | 2041-12-13 | 0 | 31 |
| 12599607 | Pharmaceutical compositions comprising timolol | 🖼🧊📄§ | 2026-04-14 | 2044-07-19 | 0 | 31 |
| 12599663 | Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation | 🖼🧊📄§ | 2026-04-14 | 2039-03-08 | 0 | 31 |
| 12599589 | Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome | 🖼🧊📄§ | 2026-04-14 | 2040-12-24 | 0 | 31 |
| 12600711 | Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors | 🖼🧊📄§ | 2026-04-14 | 2042-05-11 | 0 | 31 |
| 12600750 | Methods for inactivating and storing respiratory syncytial virus | 🖼🧊📄§ | 2026-04-14 | 2039-07-08 | 0 | 31 |
| 12599615 | Use of carotenoids in the treatment of senescence-related diseases | 🖼🧊📄§ | 2026-04-14 | 2040-03-04 | 0 | 31 |
| 12599656 | Methods for treating HPV-associated diseases | 🖼🧊📄§ | 2026-04-14 | 2039-03-11 | 0 | 31 |
| 12599698 | Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12600727 | Treatment of infections of toxoplasma gondii and closely related parasites | 🖼🧊📄§ | 2026-04-14 | 2039-09-18 | 0 | 31 |
| 12600959 | PH20 polypeptide variants, formulations and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2045-03-05 | 0 | 31 |
| 12599643 | Use of green coffee based compositions for improving insulin profile | 🖼🧊📄§ | 2026-04-14 | 2040-03-27 | 0 | 31 |
| 12599619 | Method of treating blepharitis or conjunctivitis | 🖼🧊📄§ | 2026-04-14 | 2042-05-03 | 0 | 31 |
| 12600973 | CpG ODN having immunoregulatory function and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-31 | 0 | 31 |
| 12599648 | Pharmaceutical composition comprising a combination of a guanylate cyclase C (GUCY2C) agonist and a short-chain fatty acid or prodrug thereof | 🖼🧊📄§ | 2026-04-14 | 2040-06-30 | 0 | 31 |
| 12600955 | Replication-competent recombinant herpes simplex virus type 1 (HSV-1) comprising deletions in the ICP6 and IR regions | 🖼🧊📄§ | 2026-04-14 | 2039-08-09 | 0 | 31 |
| 12599554 | Pharmaceutical formulations comprising tadalafil | 🖼🧊📄§ | 2026-04-14 | 2041-07-28 | 0 | 31 |
| 12599634 | Nerve guidance conduit comprising neural crest stem-like cells and/or Schwann cell precursor-like cells and methods of making and using the same | 🖼🧊📄§ | 2026-04-14 | 2042-09-22 | 0 | 31 |
| 12599637 | Genetically modified Lactobacillus and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-04 | 0 | 31 |
| 12599677 | Targeted PH sensitive liposomes | 🖼🧊📄§ | 2026-04-14 | 2041-10-04 | 0 | 31 |
| 12599676 | Cytotoxic imidazo[1,2-A]pyridine compounds and their use in therapy | 🖼🧊📄§ | 2026-04-14 | 2045-03-06 | 0 | 31 |
| 12599603 | Methods of treatment | 🖼🧊📄§ | 2026-04-14 | 2040-09-03 | 0 | 31 |
| 12600767 | Compounds and methods targeting epiregulin | 🖼🧊📄§ | 2026-04-14 | 2042-05-19 | 0 | 31 |
| 12600779 | LAG-3-binding molecules and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2043-11-21 | 0 | 31 |
| 12600729 | New-type benzazepine fused ring derivative | 🖼🧊📄§ | 2026-04-14 | 2042-03-04 | 0 | 31 |
| 12599654 | Immunogenic peptide fragments of metalloprotease ADAMTS-7 and uses thereof in anti-atherosclerosis and related diseases | 🖼🧊📄§ | 2026-04-14 | 2040-08-20 | 0 | 31 |
| 12599653 | Thrombolytic agents for intravascular clots | 🖼🧊📄§ | 2026-04-14 | 2040-10-19 | 0 | 31 |
| 12600778 | Rage antibodies, fragments and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-11-02 | 0 | 31 |
| 12600702 | Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-13 | 0 | 31 |
| 12600713 | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide | 🖼🧊📄§ | 2026-04-14 | 2044-02-27 | 0 | 31 |
| 12599599 | Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof | 🖼🧊📄§ | 2026-04-14 | 2043-07-20 | 0 | 31 |
| 12600724 | Indole alkaloid and preparation method and use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-11-09 | 0 | 31 |
| 12600782 | Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-30 | 0 | 31 |
| 12600796 | Constructs for chimeric antigen receptors | 🖼🧊📄§ | 2026-04-14 | 2041-09-16 | 0 | 31 |
| 12599575 | Antimicrobial adjuvant containing biphenyl derivative compound as active ingredient, and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-01-28 | 0 | 31 |
| 12599586 | Edaravone suspension for oral administration | 🖼🧊📄§ | 2026-04-14 | 2044-03-26 | 0 | 31 |
| 12599579 | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids | 🖼🧊📄§ | 2026-04-14 | 2045-07-07 | 0 | 31 |
| 12599636 | Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression | 🖼🧊📄§ | 2026-04-14 | 2038-01-19 | 0 | 31 |
| 12599635 | Compositions and treatments for ischemic injuries | 🖼🧊📄§ | 2026-04-14 | 2041-03-22 | 0 | 31 |
| 12600785 | Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene | 🖼🧊📄§ | 2026-04-14 | 2041-02-15 | 0 | 31 |
| 12600755 | Cobra 1/NELF-B as a booster for efficacy of CD8+ T cell-based therapy | 🖼🧊📄§ | 2026-04-14 | 2041-02-25 | 0 | 31 |
| 12594319 | Pharmaceutical development | 🖼🧊📄§ | 2026-04-07 | 2040-07-28 | 0 | 31 |
| 12595306 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2044-12-23 | 0 | 31 |
| 12595517 | Method to treat and stratify a patient suffering from a cancer | 🖼🧊📄§ | 2026-04-07 | 2041-09-13 | 0 | 31 |
| 12594267 | Capsid inhibitors for the treatment of HIV | 🖼🧊📄§ | 2026-04-07 | 2044-02-27 | 0 | 31 |
| 12595469 | Treatment of retinitis pigmentosa using improved engineered meganucleases | 🖼🧊📄§ | 2026-04-07 | 2041-05-11 | 0 | 31 |
| 12594236 | Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition | 🖼🧊📄§ | 2026-04-07 | 2042-05-18 | 0 | 31 |
| 12594315 | Use of Liriodendron chinense (Hemsl.) Sarg. or extract thereof in the preparation of medicament for reducing serum uric acid level and preventing and treating uric acid nephropathy | 🖼🧊📄§ | 2026-04-07 | 2040-10-23 | 0 | 31 |